𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Steatosis and fibrosis progression in patients with recurrent hepatitis C infection: Complex interactions providing diagnostic and therapeutic challenges

✍ Scribed by Stefan G. Hübscher

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
93 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Steatosis and progression of fibrosis in
Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection
✍ Ponni Perumalswami; David E. Kleiner; Glen Lutchman; Theo Heller; Brian Borg; Yo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB 👁 2 views

Hepatic steatosis is common in patients with chronic hepatitis C (CHC) and is reported to be a risk factor for progression of fibrosis. The aims of this study were to evaluate the interactions between hepatic steatosis and fibrosis in a well-defined cohort of patients with CHC. The computerized path

Impact of steatosis on progression of fi
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C
✍ Laetitia Fartoux; Olivier Chazouillères; Dominique Wendum; Raoul Poupon; Lawrenc 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

In patients with mild hepatitis C, the usefulness of antiviral therapy is subject of debate, as a low risk for progression of fibrosis is assumed. Several studies have shown that steatosis is a strong and independent predictor of the severity as well as the progression of fibrosis in chronic hepatit

A prospective evaluation of fibrosis pro
A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation
✍ Nevin Yilmaz; Mitchell L. Shiffman; R. Todd Stravitz; Richard K. Sterling; Velim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

Recurrence of hepatitis C virus (HCV) following liver transplantation (LT) is universal. A subset of these patients develop advanced fibrosis and cirrhosis and it is believed that this leads to increased posttransplantation mortality. The specific aims of this study were to determine the incidence o

One-year protocol liver biopsy can strat
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
✍ Roberto J. Firpi; Manal F. Abdelmalek; Consuelo Soldevila-Pico; Roniel Cabrera; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

Determinants of progression to cirrhosis in hepatitis C virus (HCV) infection have been well described in the immunocompetent population but remain poorly defined in liver transplant (LT) recipients. This cohort study determines the factors contributing to the development of fibrosis and its rate of

Factors influencing the progression of f
Factors influencing the progression of fibrosis in patients with recurrent hepatitis C after liver transplantation under antiviral therapy: A retrospective analysis of 939 liver biopsies in a single center
✍ Thomas Walter; Jérôme Dumortier; Olivier Guillaud; Valérie Hervieu; Jean-Yves Sc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

Recurrent hepatitis C after liver transplantation (LT) is a major problem, since up to 30% of patients develop cirrhosis only 5 years after LT in the absence of antiviral therapy. The aim of this study was to examine the rate of progression of fibrosis and its associated risk factors in patients sub